What is Cardi/o?
Cardi/o operates at the intersection of medical technology and value-based care, specializing in non-contact health monitoring systems designed for the assisted living sector. By leveraging proprietary sensing technology, the company provides real-time distress alerts and health analytics that prioritize both patient safety and individual privacy. The platform is engineered to reduce the transmission of infectious diseases, such as COVID-19, while simultaneously enhancing the economic sustainability of care facilities. By automating routine health checks, Cardi/o empowers healthcare providers to deliver precise, timely interventions, thereby optimizing resource allocation and improving long-term patient outcomes in high-density residential settings.
How much funding has Cardi/o raised?
Cardi/o has raised a total of $337K across 2 funding rounds:
Debt
$150K
Debt
$187K
Debt (2020): $150K with participation from PPP
Debt (2021): $187K led by PPP
Key Investors in Cardi/o
PPP
Public-Private Partnership
What's next for Cardi/o?
Following this major strategic investment, Cardi/o is well-positioned to accelerate its market penetration and refine its core healthtech offerings. The company's roadmap likely involves expanding its footprint across the assisted living market, where the demand for non-invasive, automated monitoring solutions continues to rise. Future growth will be driven by the integration of predictive analytics into the existing alert framework, allowing for proactive health management rather than reactive care. As the firm transitions into this next phase of development, the focus will remain on scaling operations while maintaining the high standards of data privacy and clinical accuracy that define its value proposition. The infusion of capital provides the runway required to solidify its market leadership and explore new applications for its sensing technology in broader geriatric care ecosystems.
See full Cardi/o company page
